Integral Health Asset Management as of Dec. 31, 2019
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 50 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Agilent Technologies Inc C ommon (A) | 5.7 | $15M | 170k | 85.31 | |
| Dex (DXCM) | 5.1 | $13M | 60k | 218.73 | |
| Bristol Myers Squibb (BMY) | 4.8 | $12M | 190k | 64.19 | |
| Medtronic (MDT) | 4.6 | $12M | 105k | 113.45 | |
| Amedisys (AMED) | 4.2 | $11M | 65k | 166.92 | |
| Sanofi-Aventis SA (SNY) | 3.7 | $9.5M | 190k | 50.20 | |
| BioMarin Pharmaceutical (BMRN) | 3.6 | $9.3M | 110k | 84.55 | |
| Agios Pharmaceuticals (AGIO) | 3.5 | $9.1M | 190k | 47.75 | |
| Boston Scientific Corporation (BSX) | 3.5 | $9.0M | 200k | 45.22 | |
| Sage Therapeutics (SAGE) | 3.4 | $8.7M | 120k | 72.19 | |
| Quest Diagnostics Incorporated (DGX) | 3.3 | $8.5M | 80k | 106.79 | |
| Varian Medical Systems | 3.3 | $8.5M | 60k | 142.02 | |
| Humana (HUM) | 3.3 | $8.4M | 23k | 366.52 | |
| Abbvie (ABBV) | 3.3 | $8.4M | 95k | 88.54 | |
| Teleflex Incorporated (TFX) | 3.1 | $7.9M | 21k | 376.43 | |
| Centene Corporation (CNC) | 3.1 | $7.9M | 125k | 62.87 | |
| CVS Caremark Corporation (CVS) | 2.9 | $7.4M | 100k | 74.29 | |
| Karyopharm Therapeutics (KPTI) | 2.6 | $6.6M | 345k | 19.17 | |
| Eli Lilly & Co. (LLY) | 2.6 | $6.6M | 50k | 131.44 | |
| NuVasive | 2.4 | $6.2M | 80k | 77.34 | |
| Guardant Health (GH) | 2.1 | $5.5M | 70k | 78.14 | |
| Dicerna Pharmaceuticals | 1.7 | $4.4M | 200k | 22.03 | |
| Shockwave Med | 1.5 | $4.0M | 90k | 43.92 | |
| Uniqure Nv (QURE) | 1.5 | $3.9M | 55k | 71.65 | |
| Amarin Corporation (AMRN) | 1.5 | $3.8M | 175k | 21.44 | |
| Seattle Genetics | 1.3 | $3.4M | 30k | 114.27 | |
| Arena Pharmaceuticals | 1.2 | $3.2M | 70k | 45.41 | |
| Bluebird Bio (BLUE) | 1.2 | $3.1M | 35k | 87.74 | |
| Bausch Health Companies (BHC) | 1.2 | $3.0M | 100k | 29.92 | |
| Zymeworks | 1.1 | $3.0M | 65k | 45.46 | |
| Tenet Healthcare Corporation (THC) | 1.1 | $2.9M | 75k | 38.03 | |
| Mylan Nv | 1.0 | $2.6M | 130k | 20.10 | |
| Novo Nordisk A/S (NVO) | 0.9 | $2.3M | 40k | 57.88 | |
| Incyte Corporation (INCY) | 0.8 | $2.2M | 25k | 87.32 | |
| Gw Pharmaceuticals Plc ads | 0.8 | $2.1M | 20k | 104.55 | |
| Cigna Corp (CI) | 0.8 | $2.0M | 10k | 204.50 | |
| Chemocentryx | 0.8 | $2.0M | 50k | 39.56 | |
| Mirati Therapeutics | 0.8 | $1.9M | 15k | 128.87 | |
| 10x Genomics Inc Cl A (TXG) | 0.7 | $1.9M | 25k | 76.24 | |
| Aimmune Therapeutics | 0.7 | $1.7M | 50k | 33.48 | |
| Rts/bristol-myers Squibb Compa | 0.6 | $1.7M | 550k | 3.01 | |
| Neurocrine Biosciences (NBIX) | 0.6 | $1.6M | 15k | 107.47 | |
| Nektar Therapeutics (NKTR) | 0.6 | $1.6M | 75k | 21.59 | |
| Blueprint Medicines (BPMC) | 0.6 | $1.6M | 20k | 80.10 | |
| Hologic (HOLX) | 0.6 | $1.6M | 30k | 52.20 | |
| Irhythm Technologies (IRTC) | 0.5 | $1.4M | 20k | 68.10 | |
| Minerva Neurosciences | 0.5 | $1.3M | 180k | 7.11 | |
| Apellis Pharmaceuticals (APLS) | 0.4 | $1.1M | 35k | 30.63 | |
| Gossamer Bio (GOSS) | 0.4 | $938k | 60k | 15.63 | |
| Precision Biosciences Ord | 0.3 | $695k | 50k | 13.90 |
